IL2 and cancer: Cytokines are small proteins that are essential in shaping protective antitumor immune responses, however, the utility of cytokines in the clinic for cancer immunotherapy is limited, with only TNFα, IFNα, and recombinant IL-2 approved for a small number of cancer indications (29, 49, 50).